Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial).
Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R, Sick P, Eitel I, Desch S, Schuler G; LIPSIA-NSTEMI Trial Group. Thiele H, et al. Among authors: hartmann a. Eur Heart J. 2012 Aug;33(16):2035-43. doi: 10.1093/eurheartj/ehr418. Epub 2011 Nov 21. Eur Heart J. 2012. PMID: 22108830 Clinical Trial.
Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.
Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, Hartmann A, Pfeiffer D, Kneissl GD, Schneider D, Möller T, Heberling HJ, Weise I, Schuler G; Leipzig Prehospital Fibrinolysis Group. Thiele H, et al. Among authors: hartmann a. Eur Heart J. 2005 Oct;26(19):1956-63. doi: 10.1093/eurheartj/ehi432. Epub 2005 Aug 1. Eur Heart J. 2005. PMID: 16061501 Clinical Trial.
ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G; Leipzig Prehospital Fibrinolysis Group. Thiele H, et al. Among authors: hartmann a. Am J Cardiol. 2006 Nov 1;98(9):1132-9. doi: 10.1016/j.amjcard.2006.05.044. Epub 2006 Sep 1. Am J Cardiol. 2006. PMID: 17056313 Clinical Trial.
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G; LIPSIA-STEMI Trial Group. Thiele H, et al. Among authors: hartmann a. JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013. JACC Cardiovasc Interv. 2011. PMID: 21700245 Free article. Clinical Trial.
Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
Jilek C, Lewalter T, Pauschinger M, von Scheidt W, Frankenstein L, Pfister O, Hambrecht R, Bruder O, Brachmann J, Hartmann A, Strasser R, Hochadel M, Senges J. Jilek C, et al. Among authors: hartmann a. Clin Res Cardiol. 2020 Jan;109(1):115-123. doi: 10.1007/s00392-019-01503-0. Epub 2019 Jun 24. Clin Res Cardiol. 2020. PMID: 31236690
The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry.
Meindl C, Hochadel M, Frankenstein L, Bruder O, Pauschinger M, Hambrecht R, von Scheidt W, Pfister O, Hartmann A, Maier LS, Senges J, Unsöld B. Meindl C, et al. Among authors: hartmann a. PLoS One. 2020 Jun 11;15(6):e0234260. doi: 10.1371/journal.pone.0234260. eCollection 2020. PLoS One. 2020. PMID: 32525964 Free PMC article.
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.
von Scheidt W, Zugck C, Pauschinger M, Hambrecht R, Bruder O, Hartmann A, Rauchhaus M, Zahn R, Brachmann J, Tebbe U, Neumann T, Strasser RH, Böhm M, Störk S, Hochadel M, Heidemann P, Senges J. von Scheidt W, et al. Among authors: hartmann a. Clin Res Cardiol. 2014 Dec;103(12):1006-14. doi: 10.1007/s00392-014-0743-x. Epub 2014 Jul 23. Clin Res Cardiol. 2014. PMID: 25052361 Clinical Trial.
3,393 results